Age
Item
age 21 - 60 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index 25-39 kg/m2
boolean
C1305855 (UMLS CUI [1])
Low density lipoprotein cholesterol measurement
Item
ldl cholesterol >110 mg/dl
boolean
C0202117 (UMLS CUI [1])
Age Percentile | Gender Percentile
Item
<95 percentile for age and gender for both (based on nhanes data)
boolean
C0001779 (UMLS CUI [1,1])
C1264641 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C1264641 (UMLS CUI [2,2])
Serum Triglyceride Measurement
Item
tg < 350 mg/dl
boolean
C0542495 (UMLS CUI [1])
Alcohol consumption High U/week | Gender
Item
high alcohol consumption > 21 units/week (female subjects) or > 28 units/week (male subjects)
boolean
C0001948 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
C0560588 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2])
Vitamin supplement | Mineral supplements | Vitamin supplement Discontinue Unwilling | Mineral supplements Discontinue Unwilling
Item
intake of vitamin and mineral supplements within the past 3 weeks or unwillingness to discontinue for 3 weeks prior to screening and for entire study.
boolean
C0681579 (UMLS CUI [1])
C0556112 (UMLS CUI [2])
C0681579 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C0556112 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])
Anticholesteremic Agents Prescription | Antihypertensive Agents Prescription
Item
use of prescription cholesterol-lowering or blood pressure-lowering medications during the study
boolean
C0003277 (UMLS CUI [1,1])
C0033080 (UMLS CUI [1,2])
C0003364 (UMLS CUI [2,1])
C0033080 (UMLS CUI [2,2])
Anticholesteremic Agents | Psyllium Exclusive | Fish Oil Oral Capsule Exclusive | Soy Lecithin Exclusive | Phytoestrogens Exclusive
Item
intake of other putative cholesterol-lowering supplements (excl. psyllium, fish oil capsules, soy lecithin, phytoestrogens)
boolean
C0003277 (UMLS CUI [1])
C0033979 (UMLS CUI [2,1])
C1548966 (UMLS CUI [2,2])
C1617119 (UMLS CUI [3,1])
C1548966 (UMLS CUI [3,2])
C0872912 (UMLS CUI [4,1])
C1548966 (UMLS CUI [4,2])
C0071011 (UMLS CUI [5,1])
C1548966 (UMLS CUI [5,2])
Anti-Inflammatory Agents Containing Aspirin | Anti-Inflammatory Agents Containing NSAIDs
Item
intake of anti-inflammatory medications (containing aspirin or nsaids) on a regular basis or if an acute intake, within 48 hours of a test day
boolean
C0003209 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0004057 (UMLS CUI [1,3])
C0003209 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0003211 (UMLS CUI [2,3])
Diabetes Mellitus | Liver diseases | Kidney Diseases | Thyroid Diseases | Exception Disease Controlled | Exception Thyroid Disease Stable | Exception Replacement Medication | Endocrine System Diseases
Item
diabetes, liver, kidney, thyroid (unless controlled and stable on replacement medication) or other endocrine disorders from self-reported medical history
boolean
C0011849 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0040128 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C2911690 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0040128 (UMLS CUI [6,2])
C0205360 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0559956 (UMLS CUI [7,2])
C0013227 (UMLS CUI [7,3])
C0014130 (UMLS CUI [8])
Pharmaceutical Preparations Affecting Gut | ezetimibe | Bile-acid Binding Resin | orlistat
Item
treatment with drugs acting on the gut, such as ezetimibe, bile acid-binding resins, orlistat
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0699819 (UMLS CUI [1,3])
C1142985 (UMLS CUI [2])
C2266924 (UMLS CUI [3])
C0076275 (UMLS CUI [4])
Restricted diet | Prescribed dietary intake | Slimming diet
Item
dietary restrictions such as a medically prescribed diet, or a slimming diet prior to or during the trial
boolean
C0425422 (UMLS CUI [1])
C1261371 (UMLS CUI [2])
C0521973 (UMLS CUI [3])
Weight decreased Percent of body weight | Weight Gain Percent of body weight
Item
weight loss or gain of 10% body weight or more during a period of 6 months before pre-study examination.
boolean
C1262477 (UMLS CUI [1,1])
C3476809 (UMLS CUI [1,2])
C0043094 (UMLS CUI [2,1])
C3476809 (UMLS CUI [2,2])
Blood Donation | Exception Clinical Trial Present
Item
blood/plasma donation for reason(s) other than the present study prior to the study (1 month for a male subject or 2 months for a female subject), or during the study
boolean
C0005794 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0150312 (UMLS CUI [2,3])
Breast Feeding | Pregnancy | Pregnancy, Planned
Item
lactation 6 weeks before the start of and during study, pregnant or wishing to become pregnant 3 months before or during the study
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])